Skip to main content
Smart Investors Daily
ES

OTC · ESLOY

EssilorLuxottica S.A.

Healthcare · Medical - Instruments & Supplies

$83.82

Up+$1.40 (+1.70%)

Updated Sep 29, 2026, 2:13 AM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
152.72B
P/E ratio
54.42
Dividend yield
2.69%
52-week range
— – —
Volume
32.38K
Avg. volume
53.93K

Price performance · ESLOY

ESLOY price history

1M range · 0 trading sessions · Daily adjusted prices

ESLOY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest ESLOY news

The latest Smart Investors Daily articles mentioning ESLOY.

ESLOY research

Overview

Company profile and research snapshot.

Company profile

ESSILOR LXTTCA UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
11
ESLOY recent ratings
DateFirmRatingTarget
Sep 23, 2026LANDESBANK BADEN-WUERTTEMBERGBuy—
Sep 21, 2026DAY BY DAYSell—
Sep 21, 2026EQUITA SIMBuy—
Sep 18, 2026STIFEL EUROPEBuy—
Sep 15, 2026JEFFERIESBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 24, 2026

EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect

EssilorLuxottica and Meta further advance AI glasses categorywith new products revealed at Meta Connect The two companies introduce new line of audio AI glasses and next generation of Ray-Ban Meta, the world’s leading AI glasses Paris, France and Menlo Park, California (24 September 2026) – EssilorLuxottica and Meta Platforms, the partnership behind the fast-growing smart eyewear category, unveiled the next generation of AI glasses at Meta Connect. Expanding their groundbreaking portfolio of pro

Yahoo · Sep 23, 2026

EssilorLuxottica Société Anonyme (ENXTPA:EL) Following UBS Luxury Conference Is The Growth Story Mispriced

EssilorLuxottica Société anonyme (ENXTPA:EL) took the stage at the 2026 UBS Luxury Conference on 16 September, presenting its eyewear and vision care portfolio to a luxury-focused investor audience. The UBS Luxury Conference appearance comes after a tough stretch for EssilorLuxottica Société anonyme’s shareholders, with the stock at €144.5 and the year to date share price return down 45.57%, contributing to a 46.10% decline in 1-year total shareholder return even as shorter term selling...

Yahoo · Sep 21, 2026

EssilorLuxottica: Disclosure of transactions in own shares

Disclosure of transactions in own shares Paris, France (September 21, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that on September 18, 2026, the following share buybacks were carried out: Name of the issuerIdentity code of the issuerDay of the transactionIdentity code of the financialinstrumentTotal daily volume (innumber of shares)Daily weighted averagepurchase price of the shares (€) *Market (M

Yahoo · Sep 10, 2026

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (September 10, 2026 - 6:00 pm) – As of August 31, 2026, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated b

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.